ArticleScientific reports2026
Chlamydia trachomatis serovar D replicates in uroepithelial T24/83 cells in the absence of overt inflammation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human uroepithelial bladder cancer cell line T24/83 replicates C. trachomatis serovar D efficiently. We show here that the infection with the pathogen induces significant transcription of cytokine genes such as il1β, il6 and tnf but not their secretion. Infected HeLa cells also do not release these cytokines with the exception of IL-6. In contrast, endotoxin, transfected polyI: C or infection with the uropathogenic E. coli strain CFT073 induce a robust pro-inflammatory response in T24/83 cells. These findings indicate that the cells recognize pathogen-associated molecular patterns including the TLR4 and TLR3 ligands endotoxin and dsRNA, respectively, also present in C. trachomatis serovar D. We, therefore, generated tlr4-deficient T24/83 cells to study its influence on replication of C. trachomatis serovar D. In contrast to our expectation, C. trachomatis serovar D replication in T24/83 cells did not benefit from tlr4-deficiency. TLR3 was reported to recognize C. trachomatis serovar D in the human oviduct cell line OE-E6/E7. However, tlr3-deficiency also did not improve the replication of the pathogen in T24/83 cells. Interestingly, C. trachomatis serovar D did not modulate an endotoxin-induced cytokine release but impaired significantly a polyI: C-induced and TLR3-dependent release of IFN-β. We conclude that C. trachomatis serovar D avoids an inflammatory reaction and circumvents recognition by TLR4 and TLR3 in infected uroepithelial T24/83 cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.